Literature DB >> 26050233

Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.

Gianni Masi1, Chiara Cioni1, Umberto Arrigucci2, Alfonso Cerase2, Pasquale Annunziata3.   

Abstract

Entities:  

Keywords:  Aquaporin-4; Aquaporin-4 IgG; Autoimmunity; Neuromyelitis optica; Neuromyelitis optica spectrum disorder; Transverse myelitis

Mesh：

Substances：

Year:  2015        PMID： 26050233     DOI： 10.1007/s10072-015-2277-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

Review 1.  Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders.

Authors:  Anu Jacob; Andrew McKeon; Ichiro Nakashima; Douglas Kazutoshi Sato; Liene Elsone; Kazuo Fujihara; Jerome de Seze
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-11-10       Impact factor: 10.154

2.  Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker; Karl N Krecke; Vanda A Lennon; Claudia F Lucchinetti; Andrew McKeon; Dean M Wingerchuk; Elizabeth A Shuster; Yujuan Jiao; Erika S Horta; Sean J Pittock
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

3.  Quantitative analysis of aquaporin-4 antibody in longitudinally extensive transverse myelitis.

Authors:  Jing Wang; Xin Li; Da-Qi Zhang; Chun-Sheng Yang; Yuan Qi; Min-Shu Li; Fu-Dong Shi; Li Yang
Journal:  J Neuroimmunol       Date:  2014-12-05       Impact factor: 3.478

4.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

5.  Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.

Authors:  Douglas Kazutoshi Sato; Ichiro Nakashima; Toshiyuki Takahashi; Tatsuro Misu; Patrick Waters; Hiroshi Kuroda; Shuhei Nishiyama; Chihiro Suzuki; Yoshiki Takai; Kazuo Fujihara; Yasuto Itoyama; Masashi Aoki
Journal:  Neurology       Date:  2013-05-15       Impact factor: 9.910
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.